The primary goal of the research in this competitive renewal application is to understand the role of signal transducers and activators of transcription (Stats), particularly Stat3, in epithelial carcinogenesis. During the previous funding period, through use of epidermis specific Stat3 knockout mice we discovered that Stat3 was required for de novo skin tumor development during two-stage carcinogenesis. Mechanistic studies revealed that Stat3 was required for both the initiation and promotion stages of skin carcinogenesis. During tumor initiation, further studies revealed that Stat3 is required for survival of DNA damaged keratinocytes, including those located in the hair follicle bulge region (i.e., stem cell compartment). During tumor promotion, Stat3 appears to be required for proliferation and clonal expansion of initiated cells. Additional studies using a new mouse model of constitutive Stat3 activation (K5.Stat3C mice) have indicated that Stat3 may also play a role in tumor progression in this model of multistage epithelial carcinogenesis. We have also found that Stat3 plays a significant role in UVB-mediated skin carcinogenesis both by protecting keratinocytes from UVB- induced DNA damage and by mediating keratinocyte proliferation following UVB exposure. Thus, Stat3 appears to play an important and similar role in both chemically-mediated and UVB-mediated skin carcinogenesis. Furthermore, we believe that Stat3 plays a particularly prominent role in keratinocyte stem cell (KSC) survival and proliferation based on additional data presented in the Progress Report/Preliminary Studies section including new data added since the previous review of this application. In the next funding period, we will examine Stat3 function specifically in bulge region KSCs and explore the role of specific Stat3 regulated genes in bulge region KSCs during epithelial carcinogenesis (both chemically-induced as well as UVB-induced carcinogenesis in mouse skin). The hypothesis to be tested is that Stat3 is required for both survival of bulge region KSCs during initiation and for proliferation and survival of initiated bulge region KSCs during promotion of epithelial carcinogenesis in mouse skin through regulation of specific genes involved in these processes. We will also test the hypothesis that Stat3 regulates specific genes that contribute to skin tumor progression in this model of epithelial multistage carcinogenesis.
The specific aims are: 1) to determine the impact of Stat3 deletion and Stat3 activation on gene expression patterns, growth properties and survival of bulge region KSCs during epithelial carcinogenesis in mouse skin, 2) to examine the role of specific Stat3 regulated survival genes (i.e., Bcl-xL) in bulge region KSCs during tumor initiation by DMBA and UVB, 3) to examine the role of specific Stat3 regulated cell cycle/cell proliferation genes (i.e., cyclin D1) in bulge region KSCs during tumor promotion by TPA and UVB and 4) to further explore genes regulated by Stat3 involved in tumor progression during skin carcinogenesis.

Public Health Relevance

Project Narrative The primary goal of the proposed research is to understand the role of signal transducers and activators of transcription (Stats), particularly Stat3 in epithelial carcinogenesis. Completion of the studies proposed in this grant application will lead to a greater understanding of the role Stat3 plays in epithelial carcinogenesis and its potential as a target for chemoprevention of cancer. Furthermore, the proposed studies will provide additional evidence that keratinocyte stem cells, particularly those found in the bulge region of hair follicles, may be the primary target cells for tumor development in mouse skin.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA076520-14
Application #
8272683
Study Section
Cancer Etiology Study Section (CE)
Program Officer
Johnson, Ronald L
Project Start
1998-01-07
Project End
2014-04-30
Budget Start
2012-05-01
Budget End
2014-04-30
Support Year
14
Fiscal Year
2012
Total Cost
$299,504
Indirect Cost
$99,144
Name
University of Texas Austin
Department
Pharmacology
Type
Schools of Pharmacy
DUNS #
170230239
City
Austin
State
TX
Country
United States
Zip Code
78712
Bozeman, Ronald; Abel, Erika L; Macias, Everardo et al. (2015) A novel mechanism of skin tumor promotion involving interferon-gamma (IFN?)/signal transducer and activator of transcription-1 (Stat1) signaling. Mol Carcinog 54:642-53
Macias, Everardo; Rao, Dharanija; Carbajal, Steve et al. (2014) Stat3 binds to mtDNA and regulates mitochondrial gene expression in keratinocytes. J Invest Dermatol 134:1971-80
Yokogawa, Maki; Takaishi, Mikiro; Nakajima, Kimiko et al. (2013) Imiquimod attenuates the growth of UVB-induced SCC in mice through Th1/Th17 cells. Mol Carcinog 52:760-9
Rho, Okkyung; Kim, Dae Joon; Kiguchi, Karou et al. (2011) Growth factor signaling pathways as targets for prevention of epithelial carcinogenesis. Mol Carcinog 50:264-79
Swindell, William R; Johnston, Andrew; Carbajal, Steve et al. (2011) Genome-wide expression profiling of five mouse models identifies similarities and differences with human psoriasis. PLoS One 6:e18266
Kim, Dae Joon; Tremblay, Michel L; Digiovanni, John (2010) Protein tyrosine phosphatases, TC-PTP, SHP1, and SHP2, cooperate in rapid dephosphorylation of Stat3 in keratinocytes following UVB irradiation. PLoS One 5:e10290
Kiguchi, Kaoru; Kitamura, Takuya; Moore, Tricia et al. (2010) Dual inhibition of both the epidermal growth factor receptor and erbB2 effectively inhibits the promotion of skin tumors during two-stage carcinogenesis. Cancer Prev Res (Phila) 3:940-52
Syed, Zanobia; Cheepala, Satish B; Gill, Jennifer N et al. (2009) All-trans retinoic acid suppresses Stat3 signaling during skin carcinogenesis. Cancer Prev Res (Phila Pa) 2:903-11
Kim, Dae Joon; Kataoka, Ken; Rao, Dharanija et al. (2009) Targeted disruption of stat3 reveals a major role for follicular stem cells in skin tumor initiation. Cancer Res 69:7587-94
Kim, Dae Joon; Kataoka, Ken; Sano, Shigetoshi et al. (2009) Targeted disruption of Bcl-xL in mouse keratinocytes inhibits both UVB- and chemically induced skin carcinogenesis. Mol Carcinog 48:873-85

Showing the most recent 10 out of 24 publications